|
ATCC
crl Crl, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/pm42258350-239-196-194?v=ATCC Average 96 stars, based on 1 article reviews
crl - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
MedChemExpress
complement c3/c3a, mouse Complement C3/C3a, Mouse, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/custom%40hy-p7863%4042464680?v=MedChemExpress Average 93 stars, based on 1 article reviews
complement c3/c3a, mouse - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
Hycult Biotech
c3a, mouse, mab 3/11 C3a, Mouse, Mab 3/11, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/custom%40hm1072%4042527662?v=Hycult+Biotech Average 92 stars, based on 1 article reviews
c3a, mouse, mab 3/11 - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
ATCC
cell lines hepg2 c3a atcc Cell Lines Hepg2 C3a Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/pm42258350-239-191-194?v=ATCC Average 99 stars, based on 1 article reviews
cell lines hepg2 c3a atcc - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
ATCC
hepatocellular carcinoma hepg2 c3a cell line ![]() Hepatocellular Carcinoma Hepg2 C3a Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/bio_rxiv__64898__2026__05__29__728167-167-2-11?v=ATCC Average 99 stars, based on 1 article reviews
hepatocellular carcinoma hepg2 c3a cell line - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
ATCC
hepg2 c3a cells ![]() Hepg2 C3a Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/us12630839-1083-0-8?v=ATCC Average 99 stars, based on 1 article reviews
hepg2 c3a cells - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
|
ATCC
c3a subclone ![]() C3a Subclone, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/pmc13159537-88-53-66?v=ATCC Average 96 stars, based on 1 article reviews
c3a subclone - by Bioz Stars,
2026-08
96/100 stars
|
Buy from Supplier |
|
MedChemExpress
c3a ![]() C3a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/pm42047759-102-9-33?v=MedChemExpress Average 93 stars, based on 1 article reviews
c3a - by Bioz Stars,
2026-08
93/100 stars
|
Buy from Supplier |
|
ATCC
human hepatocellular carcinoma hepg2 c3a ![]() Human Hepatocellular Carcinoma Hepg2 C3a, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/c3a/pmc13112599-173-15-25?v=ATCC Average 99 stars, based on 1 article reviews
human hepatocellular carcinoma hepg2 c3a - by Bioz Stars,
2026-08
99/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: Histone succinylation directly inhibits Jumonji domain demethylases and stabilizes repressive chromatin states
doi: 10.64898/2026.05.29.728167
Figure Lengend Snippet: (A) Global histone succinylation measured by LC-MS/MS in HepG2/C3A cells following 48 hours of sodium succinate treatment. (B) Global histone succinylation in 3D cultured HepG2/C3A spheroids following 48 hours and 1 week of sodium succinate treatment. (C) Comparison of the relative abundance of succinyl-lysine residues in H3 and H4, in either treated or untreated, cultured cells (2D) or spheroids (3D). (D) Structure of the nucleosome with H3K64 residues highlighted to demonstrate solvent accessibility. (E) Abundance of succinyl-CoA in the nuclear fraction (left) and non-nuclear fraction (right) following sodium succinate treatment. (F) Total count of HepG2/C3A cells treated with 10 mM sodium succinate continuously for 48 to 144 hours, cell count taken every 48 hours. Data are shown as mean ± SEM; * p-value <0 . 05 in two-tailed Student’s t-test .
Article Snippet: The human
Techniques: Liquid Chromatography with Mass Spectroscopy, Cell Culture, Comparison, Solvent, Cell Characterization, Two Tailed Test
Journal: bioRxiv
Article Title: Histone succinylation directly inhibits Jumonji domain demethylases and stabilizes repressive chromatin states
doi: 10.64898/2026.05.29.728167
Figure Lengend Snippet: (A) Schematic of peptide pull-down technique used to identify potential protein interactors with histone succinylation. (B) Volcano plot of fold change and significance of enrichment of nuclear proteins from HepG2/C3A cells to a Ksu synthetic peptide vs. Kac synthetic peptide. (C) Volcano plot of fold change and significance of enrichment of bromodomain proteins to Ksu synthetic histone peptide as compared to the Kac peptide, and (D) Ksu synthetic histone peptide as compared to an unmodified peptide. (E) Volcano plot of fold change and significance of enrichment of JmjC domain demethylases to Ksu synthetic histone peptide as compared to an Kac peptide and (F) Ksu synthetic histone peptide as compared to an unmodified peptide. (G) Crystal structure (PDB 6F6D) of an unmodified histone H3 peptide in the catalytic site of KDM6B. (H) Boltz2 model of a Ksu peptide (AARK(succinyl)A) in the catalytic site of KDM6B. (I) Enrichment of JmjC-domain demethylases to the chromatin-bound proteome of HepG2/C3A cells treated with 10 mM sodium succinate for 48 hours. A -log2 p-value greater than 4 indicates significant enrichment .
Article Snippet: The human
Techniques:
Journal: bioRxiv
Article Title: Histone succinylation directly inhibits Jumonji domain demethylases and stabilizes repressive chromatin states
doi: 10.64898/2026.05.29.728167
Figure Lengend Snippet: (A) Known targets of JmjC domain demethylase family enzymes. (B) Relative abundance of methylation on targets of JmjC domain demethylases in HepG2/C3A cells treated with sodium succinate. (C) Relative abundance of methylation on targets of JmjC domain demethylases in HepG2/C3A 3D cells treated with sodium succinate. (D) ChIP-MS shows co-enrichment of succinylated histone peptides with H3K27me3 peptides. Data are shown as mean ± SEM; *p-value <0 . 05, **p-value <0 . 01 in two-tailed Student’s t-test .
Article Snippet: The human
Techniques: Methylation, Two Tailed Test
Journal: BioMed Research International
Article Title: In Vitro Antidiabetic Activity and Mechanism of Action of Methanolic Extract of Opuntia stricta Cladodes
doi: 10.1155/bmri/9325356
Figure Lengend Snippet: Cell viability (%). (A) L6 myoblast cells and (B) C3A cells after 24 h of exposure to treatment as indicated.
Article Snippet: The INS‐1 cells ( Rattus norvegicus , male, pancreatic β ‐cell; AddexBio, RRID:CVCL_0351), Caco‐2 cells ( Homo sapiens , male, colon epithelium; American Type Culture Collection [ATCC] HTB‐37, RRID:CVCL_0025), and L6 myoblasts ( Rattus norvegicus , male, skeletal muscle myoblast; RIKEN Cell Bank, RRID:CVCL_0385) were procured from Highveld Biological, South Africa, while the
Techniques:
Journal: BioMed Research International
Article Title: In Vitro Antidiabetic Activity and Mechanism of Action of Methanolic Extract of Opuntia stricta Cladodes
doi: 10.1155/bmri/9325356
Figure Lengend Snippet: Glucose utilization (%) after 24 h of treatment in (A) L6 myoblasts and (B) C3A hepatocytes.
Article Snippet: The INS‐1 cells ( Rattus norvegicus , male, pancreatic β ‐cell; AddexBio, RRID:CVCL_0351), Caco‐2 cells ( Homo sapiens , male, colon epithelium; American Type Culture Collection [ATCC] HTB‐37, RRID:CVCL_0025), and L6 myoblasts ( Rattus norvegicus , male, skeletal muscle myoblast; RIKEN Cell Bank, RRID:CVCL_0385) were procured from Highveld Biological, South Africa, while the
Techniques:
Journal: BioMed Research International
Article Title: In Vitro Antidiabetic Activity and Mechanism of Action of Methanolic Extract of Opuntia stricta Cladodes
doi: 10.1155/bmri/9325356
Figure Lengend Snippet: Glucose uptake (%) after 4 h in (A) L6 myoblasts and (B) C3A hepatocytes following a 24‐h treatment period.
Article Snippet: The INS‐1 cells ( Rattus norvegicus , male, pancreatic β ‐cell; AddexBio, RRID:CVCL_0351), Caco‐2 cells ( Homo sapiens , male, colon epithelium; American Type Culture Collection [ATCC] HTB‐37, RRID:CVCL_0025), and L6 myoblasts ( Rattus norvegicus , male, skeletal muscle myoblast; RIKEN Cell Bank, RRID:CVCL_0385) were procured from Highveld Biological, South Africa, while the
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Effect of 10 Gy X‐ray on viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells. Blue: untreated controls; Pink: irradiated cells. Cell counts were conducted at 24, 48, and 72 h post‐treatment. Statistical analysis was performed using two‐way ANOVA with Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Note: Y ‐axes are scaled independently for each cell line to account for differences in baseline growth, allowing clearer visualization of treatment effects. Tumor cell counts and representative images can be found in Appendix Table and Figure .
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques: Irradiation
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of untreated NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells and cells exposed to X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Viability of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells after treatment with IMP‐1700 (5 µM), ciprofloxacin (CPX) (15 µM), their combination, or DMSO, with and without 10 Gy X‐ray. Cell counts were measured at 24, 48, and 72 h post‐treatment. Statistical significance assessed via two‐way ANOVA and Tukey's post hoc test: p < 0.05 (*), p < 0.005 (**), p < 0.0005 (***), p < 0.0001 (****), n = 3. Significant differences are only shown compared to untreated or 10 Gy. Tumor cell count values and images are available in Appendix Table and Figure , , , .
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques: Cell Characterization
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700, with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with IMP‐1700 and ciprofloxacin (CPX), with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques:
Journal: MicrobiologyOpen
Article Title: Synergistic Effects of IMP‐1700, Ciprofloxacin, and X‐Ray Radiation in Bacteria and Mammalian Cell Lines: Implications for Use in Antimicrobial‐Resistant Bacteria
doi: 10.1002/mbo3.70270
Figure Lengend Snippet: Images of NIH‐3T3, B16.F10, MDA‐MB‐231, and HepG2 cells treated with DMSO, with and without X‐ray. Scalebar: 300 µm.
Article Snippet: The tumor cell lines, mouse melanoma B16.F10 (CRL‐6475, ATCC), human breast cancer MB‐MDA‐231 (CRM‐HTB‐26, ATCC),
Techniques: